Cargando…

Selective modulation of P-glycoprotein-mediated drug resistance

Multidrug resistance associated with the overexpression of the multidrug transporter P-glycoprotein is a serious impediment to successful cancer treatment. We found that verapamil reversed resistance of CEM/VLB (100) cells to vinblastine and fluorescein-colchicine, but not to colchicine. Chlorpromaz...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bebawy, M, Morris, M B, Roufogalis, B D
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2001
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364021/ https://www.ncbi.nlm.nih.gov/pubmed/11747345 http://dx.doi.org/10.1054/bjoc.2001.2184

Ejemplares similares

In vivo efficacy of XR9051, a potent modulator of P-glycoprotein mediated multidrug resistance
por: Mistry, P, et al.
Publicado: (1999)

Selective inhibition of MDR1 P-glycoprotein-mediated transport by the acridone carboxamide derivative GG918
por: Wallstab, A, et al.
Publicado: (1999)

The acridonecarboxamide GF120918 potently reverses P-glycoprotein-mediated resistance in human sarcoma MES-Dx5 cells
por: Traunecker, H C L, et al.
Publicado: (1999)

Proteins regulating the intercellular transfer and function of P-glycoprotein in multidrug-resistant cancer
por: Pokharel, Deep, et al.
Publicado: (2017)

Osteoblastic differentiation and P-glycoprotein multidrug resistance in a murine osteosarcoma model
por: Takeshita, H, et al.
Publicado: (2000)

Effect of P-glycoprotein on flavopiridol sensitivity
por: Boerner, S A, et al.
Publicado: (2001)

Genistein modulates the decreased drug accumulation in non-P-glycoprotein mediated multidrug resistant tumour cells.
por: Versantvoort, C. H., et al.
Publicado: (1993)

The equilibrium and kinetic drug binding properties of the mouse P-gp1a and P-gp1b P-glycoproteins are similar
por: Taylor, J C, et al.
Publicado: (1999)

P glycoprotein (P-gp) and drug resistance--time for reappraisal?
por: Kaye, S. B.
Publicado: (1993)

Hypoxia-induced drug resistance: comparison to P-glycoprotein-associated drug resistance.
por: Sakata, K., et al.
Publicado: (1991)

Ecdysteroid Derivatives that Reverse P-Glycoprotein-Mediated Drug Resistance
por: Bortolozzi, Roberta, et al.
Publicado: (2020)

Inhibition of P-glycoprotein by two artemisinin derivatives
por: Steglich, Babette, et al.
Publicado: (2012)

Characterization of a P-glycoprotein drug transporter from Toxocara canis with a novel pharmacological profile
por: Jesudoss Chelladurai, Jeba R.J., et al.
Publicado: (2021)

Modulation of p-glycoprotein-mediated efflux pirarubicin in living multidrug-resistant K562/Dox cell lines by 4-hydroxybenzoic acid and 4-hydroxy-3-methoxybenzoic acid via impairment of the cellular energetic state
por: Myint, Ohnmar, et al.
Publicado: (2022)

Comparison of (99m)Tc-sestamibi and doxorubicin to monitor inhibition of P-glycoprotein function
por: Muzzammil, T, et al.
Publicado: (2001)

The endocytic receptor protein LRP-1 modulate P-glycoprotein mediated drug resistance in MCF-7 cells
por: Henry, Aubery, et al.
Publicado: (2023)

Modulation of DNA topoisomerase II activity and expression in melanoma cells with acquired drug resistance
por: Lage, H, et al.
Publicado: (2000)

Selective modulation of brain network dynamics by seizure therapy in treatment-resistant depression
por: Atluri, Sravya, et al.
Publicado: (2018)

Indomethacin-mediated reversal of multidrug resistance and drug efflux in human and murine cell lines overexpressing MRP, but not P-glycoprotein.
por: Draper, M. P., et al.
Publicado: (1997)

P-Glycoprotein and Drug Resistance in Systemic Autoimmune Diseases
por: Picchianti-Diamanti, Andrea, et al.
Publicado: (2014)

Antitumour activity of novel taxanes that act at the same time as cytotoxic agents and P-glycoprotein inhibitors
por: Ferlini, C, et al.
Publicado: (2000)

The Role of CD44 and ERM Proteins in Expression and Functionality of P-glycoprotein in Breast Cancer Cells
por: Pokharel, Deep, et al.
Publicado: (2016)

Carbon nano-onion-mediated dual targeting of P-selectin and P-glycoprotein to overcome cancer drug resistance
por: Wang, Hai, et al.
Publicado: (2021)

Acquired Drug Resistance Enhances Imidazoquinoline Efflux by P-Glycoprotein
por: Pulukuri, Anunay J., et al.
Publicado: (2021)

Study Models of Drug–Drug Interactions Involving P-Glycoprotein: The Potential Benefit of P-Glycoprotein Modulation at the Kidney and Intestinal Levels
por: Veiga-Matos, Jéssica, et al.
Publicado: (2023)

Characterization and modulation of drug resistance of human paediatric rhabdomyosarcoma cell lines
por: Cocker, H A, et al.
Publicado: (2000)

Lipoproteins modulate growth and P-glycoprotein expression in drug-resistant HER2-overexpressed breast cancer cells
por: Siti, Z.S., et al.
Publicado: (2019)

Reversal Effect of Oxypeucedanin on P-glycoprotein-mediated Drug Transport
por: Dong, Wei, et al.
Publicado: (2018)

Modulation of Cytochrome P450, P-glycoprotein and Pregnane X Receptor by Selected Antimalarial Herbs—Implication for Herb-Drug Interaction
por: Fasinu, Pius S., et al.
Publicado: (2017)

Predicting P-Glycoprotein-Mediated Drug Transport Based On Support Vector Machine and Three-Dimensional Crystal Structure of P-glycoprotein
por: Bikadi, Zsolt, et al.
Publicado: (2011)

The Syk inhibitor R406 is a modulator of P-glycoprotein (ABCB1)-mediated multidrug resistance
por: Duran, George E., et al.
Publicado: (2019)

Increased accumulation of doxorubicin and doxorubicinol in cardiac tissue of mice lacking mdr1a P-glycoprotein
por: Asperen, J van, et al.
Publicado: (1999)

Mechanism of multidrug resistance to chemotherapy mediated by P-glycoprotein (Review)
por: Tian, Yichen, et al.
Publicado: (2023)

P‐Glycoprotein Mediated Drug Interactions in Animals and Humans with Cancer
por: Mealey, K.L., et al.
Publicado: (2015)

Degradation of P-glycoprotein by pristimerin contributes to overcoming ABCB1-mediated chemotherapeutic drug resistance in vitro
por: Yan, Yan-Yan, et al.
Publicado: (2017)

Different types of non-P-glycoprotein mediated multiple drug resistance in children with relapsed acute lymphoblastic leukaemia.
por: Pieters, R., et al.
Publicado: (1992)

Flavonoids modulate multidrug resistance through wnt signaling in P-glycoprotein overexpressing cell lines
por: Mohana, S., et al.
Publicado: (2018)

Potentiation of the cytotoxicity of thymidylate synthase (TS) inhibitors by dipyridamole analogues with reduced α(1)-acid glycoprotein binding
por: Curtin, N J, et al.
Publicado: (1999)

Bromocriptine Reverses P‐Glycoprotein‐mediated Multidrug Resistance in Tumor Cells
por: Shiraki, Nobuaki, et al.
Publicado: (2002)

Chromogranin A and the α -subunit of glycoprotein hormones in medullary thyroid carcinoma and phaeochromocytoma
por: Guignat, L, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_b8d0632dkiice7sg705oj98dks